JP2011526920A5 - - Google Patents

Download PDF

Info

Publication number
JP2011526920A5
JP2011526920A5 JP2011516843A JP2011516843A JP2011526920A5 JP 2011526920 A5 JP2011526920 A5 JP 2011526920A5 JP 2011516843 A JP2011516843 A JP 2011516843A JP 2011516843 A JP2011516843 A JP 2011516843A JP 2011526920 A5 JP2011526920 A5 JP 2011526920A5
Authority
JP
Japan
Prior art keywords
lysin
chimeric
peptide
seq
bacteriophage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011516843A
Other languages
English (en)
Japanese (ja)
Other versions
JP5758291B2 (ja
JP2011526920A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/049349 external-priority patent/WO2010002959A2/en
Publication of JP2011526920A publication Critical patent/JP2011526920A/ja
Publication of JP2011526920A5 publication Critical patent/JP2011526920A5/ja
Application granted granted Critical
Publication of JP5758291B2 publication Critical patent/JP5758291B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011516843A 2008-07-03 2009-07-01 Staphylococcibacteriaに対する活性を有するキメラバクテリオファージ溶解素 Expired - Fee Related JP5758291B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7827708P 2008-07-03 2008-07-03
US61/078,277 2008-07-03
PCT/US2009/049349 WO2010002959A2 (en) 2008-07-03 2009-07-01 A chimeric bacteriophage lysin with activity against staphylococci bacteria

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015033626A Division JP6169632B2 (ja) 2008-07-03 2015-02-24 Staphylococcibacteriaに対する活性を有するキメラバクテリオファージ溶解素

Publications (3)

Publication Number Publication Date
JP2011526920A JP2011526920A (ja) 2011-10-20
JP2011526920A5 true JP2011526920A5 (https=) 2012-08-16
JP5758291B2 JP5758291B2 (ja) 2015-08-05

Family

ID=41466590

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2011516843A Expired - Fee Related JP5758291B2 (ja) 2008-07-03 2009-07-01 Staphylococcibacteriaに対する活性を有するキメラバクテリオファージ溶解素
JP2015033626A Expired - Fee Related JP6169632B2 (ja) 2008-07-03 2015-02-24 Staphylococcibacteriaに対する活性を有するキメラバクテリオファージ溶解素

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015033626A Expired - Fee Related JP6169632B2 (ja) 2008-07-03 2015-02-24 Staphylococcibacteriaに対する活性を有するキメラバクテリオファージ溶解素

Country Status (8)

Country Link
US (4) US8840900B2 (https=)
EP (2) EP2307557B1 (https=)
JP (2) JP5758291B2 (https=)
AU (2) AU2009266982B2 (https=)
CA (2) CA2729160C (https=)
ES (1) ES2627321T3 (https=)
HK (1) HK1248722A1 (https=)
WO (1) WO2010002959A2 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8389469B2 (en) 2005-06-06 2013-03-05 The Rockefeller University Bacteriophage lysins for Bacillus anthracis
EP2360248A1 (en) 2005-08-24 2011-08-24 The Rockefeller University Ply-GBS mutant lysins
DK2699253T3 (en) 2011-04-21 2018-07-16 Univ Rockefeller STREPTOCOCCUS BACTERYPHAGIC LYSINES FOR THE DETECTION AND TREATMENT OF GRAM POSITIVE BACTERIES
DK3085777T3 (da) * 2011-05-04 2020-02-03 Micreos Human Health Bv Polypeptid
US9279118B2 (en) 2011-10-05 2016-03-08 The Rockefeller University Dimeric bacteriophage lysins
RU2018121290A (ru) 2012-05-09 2019-03-06 Контрафект Корпорейшн Комбинации лизина бактериофага и антибиотика против грам-положительных бактерий
BR112014027818B1 (pt) * 2012-05-09 2023-03-28 Contrafect Corporation Usos de composições compreendendo polipeptídeo de lisina para prevenção, ruptura ou tratamento de um biofilme bacteriano
CN103122347B (zh) * 2013-02-01 2015-04-22 中国科学院武汉病毒研究所 一种杀灭葡萄球菌的裂解酶及其应用
ES2525954B1 (es) * 2013-05-28 2015-10-23 Consejo Superior De Investigaciones Científicas (Csic) Enzibióticos bactericidas mejorados frente a neumococo y otras bacterias
CN104762285B (zh) * 2015-04-23 2017-10-27 武汉菲吉乐科生物科技有限公司 一种自内裂解大肠杆菌的裂解酶及其应用
CN104805066B (zh) * 2015-05-18 2018-04-24 武汉菲吉乐科生物科技有限公司 一种葡萄球菌裂解酶及其应用
EP3454888B1 (en) 2016-05-12 2021-02-24 Contrafect Corporation Broth microdilution method for evaluating and determining minimal inhibitory concentration of antibacterial polypeptides
BR112020026267A2 (pt) * 2018-06-22 2021-04-06 Contrafect Corporation Lisinas e seus derivados resensibilizam novamente staphylococcus aureus e bactérias gram-positivas aos antibióticos
WO2020032232A1 (ja) * 2018-08-10 2020-02-13 Meiji Seikaファルマ株式会社 バクテリオファージ剤
CN109666667A (zh) * 2019-01-22 2019-04-23 上海交通大学 杀灭金黄色葡萄球菌的嵌合酶抗生素及其制备和应用
WO2021084558A2 (en) * 2019-10-31 2021-05-06 Bactoclear Holdings Pte. Ltd Chimeric proteins for selective lysis of bacteria
WO2021178968A1 (en) * 2020-03-06 2021-09-10 Endolytix Technology, Inc. Compositions and methods for the treatment of intracellular bacterial infections
WO2021180892A1 (en) * 2020-03-11 2021-09-16 Telum Therapeutics S.L. New recombinant lysin and its use in the treatment of gram-negative bacterial infections
CN111808837A (zh) * 2020-07-17 2020-10-23 青岛诺安百特生物技术有限公司 一种金黄色葡萄球菌噬菌体裂解酶及其制备方法和应用
CN115820616A (zh) * 2022-07-22 2023-03-21 昆明理工大学 一种带荧光标记的噬菌体裂解酶及其应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997008553A1 (en) * 1995-08-22 1997-03-06 The Regents Of The University Of California Targeting of proteins to the cell wall of gram-positive bacteria
US6056954A (en) * 1997-10-31 2000-05-02 New Horizons Diagnostics Corp Use of bacterial phage associated lysing enzymers for the prophylactic and therapeutic treatment of various illnesses
US6703025B1 (en) * 1998-08-31 2004-03-09 Inhibitex, Inc. Multicomponent vaccines
US20020127215A1 (en) * 1999-09-14 2002-09-12 Lawrence Loomis Parenteral use of bacterial phage associated lysing enzymes for the therapeutic treatment of bacterial infections
GB0107661D0 (en) * 2001-03-27 2001-05-16 Chiron Spa Staphylococcus aureus
US20040213765A1 (en) * 2001-07-13 2004-10-28 Vincent Fischetti Use of bacterial phage associated lytic enzymes to prevent food poisoning
EP1504088B1 (en) * 2002-03-25 2007-08-15 University Of Warwick Bacteriophages useful for therapy and prophylaxis of bacterial infections
JPWO2004020635A1 (ja) * 2002-08-28 2005-12-15 株式会社テクノネットワーク四国 バクテリオファージおよび細菌感染症治療剤
EP2360248A1 (en) * 2005-08-24 2011-08-24 The Rockefeller University Ply-GBS mutant lysins
WO2009024327A2 (en) 2007-08-22 2009-02-26 Profos Ag New proteins for use in human and animal staphylococcus infections
US8563504B2 (en) * 2008-10-10 2013-10-22 Lusomedicamenta, S.A. Antibacterial phage peptides and methods of use thereof
AU2010211456B2 (en) * 2009-02-06 2016-05-26 Technophage, Investigação E Desenvolvimento Em Biotecnologia, S.A. Antibacterial phage, phage peptides and methods of use thereof

Similar Documents

Publication Publication Date Title
JP2011526920A5 (https=)
Yasir et al. Mechanism of action of surface immobilized antimicrobial peptides against Pseudomonas aeruginosa
US11827911B2 (en) Chimeric bacteriophage lysin with activity against Staphylococci bacteria
Pangule et al. Antistaphylococcal nanocomposite films based on enzyme− nanotube conjugates
Fenton et al. Bacteriophage‐derived peptidase CHAPk eliminates and prevents staphylococcal biofilms
US20140082769A1 (en) Molecules and methods for inhibition and detection of proteins
JP2018509415A (ja) 細菌感染の治療方法
WO2010080836A2 (en) Antibacterial and antifungal peptides
KR101796279B1 (ko) 새로운 호스트 바인딩 도메인을 갖는 포도상구균 박테리오파지 SA11 유래의 엔도라이신 LysSA11 및 이를 포함하는 세균 사멸용 조성물
KR20200045468A (ko) 용균 단백질 항균 활성의 혈액 성분 강화 및 이의 방법 및 용도
Bhagwat et al. Opportunities for broadening the application of cell wall lytic enzymes
Sabulski et al. Immuno-targeting of Staphylococcus aureus via surface remodeling complexes
JP2020500535A (ja) 修飾型ペプチド
Opitakorn et al. Non-leaching antibacterial cotton fabrics based on lipidated peptides
CA3175923A1 (en) A chimeric endolysin polypeptide.
JP2017522280A (ja) 特に獣医学分野用の消毒剤および抗微生物組成物
ES2346808T3 (es) Composiciones antimicrobianas que comprenden un peptido cationico y una endopeptidasa de glicilglicina.
EP1066045A4 (en) Mammalian-derived peptides for the treatment of microbial infection
Nakamura et al. Development of a bioactive fiber with immobilized synthetic peptides designed from the active site of a beetle defensin
Artini et al. Holo and apo-transferrins interfere with adherence to abiotic surfaces and with adhesion/invasion to HeLa cells in Staphylococcus spp.
WO2018126108A1 (en) Bacteriophage having modified recognition baseplate protein structural domains
Gottschalk et al. The lysine-peptoid hybrid LP5 maintain activity under physiological conditions and affects virulence gene expression in Staphylococcus aureus
Rao et al. A novel phage endolysin inactivates a wide range of Staphylococcus aureus and eliminates mono-and mixed-species biofilms associated with S. aureus
Perkins Clumping factor B (ClfB), a Staphylococcus aureus surface protein
JP2004522945A5 (https=)